Fritextsökning
Innehållstyper
-
Lovande resultat för atogepant som förebyggande behandling mot migrän
Behandling med läkemedelskandidaten atogepant gav en signifikant minskning av antalet dagar med migrän eller huvudvärk hos patienter i en fas III-studie.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Grape extract kills cancer cells
Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
New Nordic biotech company
The Swiss biotech company Tillots Pharma opens a office in Stockholm, which will be run under private management.
-
Next generation sequencer in an accessible format
The GS Junior System is a new benchtop-sized next generation sequencing platform.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Konferens om läkemedelsformuleringar samlade forskare i Köpenhamn
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
Google och Abbvie i miljardsamarbete
Googles spinoff-bolag Calico ingår ett samarbete med läkemedelsjätten Abbvie.
-
Travelling scholarship to DTU professor
The Vera og Carl Johan Michaelsens Rejselegat has the founder of the Medicine and Technology program at DTU with a scholarship.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Snart faller klubban för Astrazeneca
I dag torsdag hålls slutpläderingarna i det första pay-for-delay-fallet i USA, som kan ge läkemedelsbolaget miljarder dollar i böter.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Så går prestigetidskrifterna vidare efter Surgisphere-gate
I våras fick två av de högst rankade medicinska tidskrifterna dra tillbaka studier om covid-19. Vi ställde frågan vilka åtgärder de tagit för att inte upprepa misstagen.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Näthandeln är en stor utmaning för småföretagarna
Att sätta upp en webbshop är enkelt idag. Men att ranka högt på Google är betydligt svårare.
-
David Julius och Ardem Patapoutian får Nobelpriset i medicin
De två Nobelpristagarnas forskning kan komma att få tillämpningar för behandling av kronisk smärta.